Breast pain is common, usually benign, and rarely a sign of cancer

Breast pain — mastalgia — is one of the most common symptoms women experience over a lifetime, and the reassuring fact underneath the worry is that it is usually self-limited and rarely caused by cancer [s1]. That does not mean it should be ignored, but it does mean the default interpretation most women reach for is, statistically, the wrong one.

What breast pain usually is

A clinical review of mastalgia sorts it into three categories: cyclic pain, tied to the menstrual cycle; noncyclic pain, not linked to the cycle and often originating in the breast tissue itself; and extramammary pain, which comes from outside the breast, such as the chest wall, but is felt there [s1]. The review lists the ordinary contributors to the physiologic kinds — diet, medications, stress, hormonal fluctuations, and even an ill-fitting bra — none of which are sinister [s1].

On the question women most want answered, the review is direct: breast cancer "is rarely a cause" of mastalgia, though it "should be excluded" through a good history, examination and targeted imaging where warranted [s1]. Both halves matter. Pain alone is an uncommon presentation of breast cancer, so its presence is not the alarm signal it feels like; but because the consequence of missing a cancer is serious, the standard approach is to evaluate rather than simply dismiss, particularly when pain is focal, persistent, or accompanied by a lump or other change [s1].

What actually helps

The review's treatment list starts with the least invasive options: reassurance, support, dietary changes, and nonsteroidal anti-inflammatory drugs, with hormonal medications reserved as an occasional step for more severe or refractory pain [s1]. The prominence of reassurance is not a euphemism for doing nothing — for a symptom that is usually benign and often resolves on its own, an accurate understanding of what the pain is, and is not, is itself a large part of the management.

The ordering also implies what the evidence does not support: jumping to a drug for a symptom that frequently settles by itself. Hormonal treatments for breast pain carry their own side-effect profiles, which is why they sit at the end of the list rather than the front, and any decision about them is a clinical one this article does not attempt to make.

A popular remedy without the evidence

Vitamin B6 is widely suggested for breast pain, in the same folk-remedy register as evening primrose oil. A 2025 systematic review and meta-analysis tested it directly [s2]. From an initial pool of studies covering 951 participants, only three trials were suitable to combine, and the pooled result showed no difference between vitamin B6 and placebo in pain reduction (standardised mean difference -3.57, 95% confidence interval -9.15 to 2.01) [s2]. The reviewers rated the certainty of that evidence as very low, with extreme statistical heterogeneity between the studies (I² of 99.56%) and low overall study quality [s2].

That combination — a wide confidence interval crossing no effect, very low certainty, and near-total heterogeneity — is what "no good evidence" looks like in practice. It does not prove B6 useless; it means the studies that exist are too few, too small and too inconsistent to show a benefit if one exists. For a supplement recommended casually and often, that is a meaningful gap, and it is the kind of thing the popular advice rarely mentions.

The honest summary

Breast pain is common, usually benign, frequently cyclic, and only rarely a sign of cancer — which is nonetheless worth excluding when the pattern warrants it [s1]. The first-line responses are conservative and low-risk, and at least one widely recommended supplement, vitamin B6, lacks the evidence to justify the confidence with which it is suggested [s1] [s2]. The reassurance is real, and it is evidence-based rather than dismissive.

This article is informational and is not medical advice. New, focal, or persistent breast pain, or pain with a lump or other change, should be evaluated by a clinician.